Pharmaceuticals
Few patients continue weight loss drugs like Wegovy after a year — but health costs soar for all
A selection of injector pens for the Wegovy weight loss drug are shown in this photo illustration in Chicago, Illinois, March 31, 2023. Jim Vondruska | Reuters Only around one-third of patients prescribed weight loss drugs such as Novo Nordisk‘s blockbuster injection Wegovy continued to take it a year later — but total health-care costs […]
Read More
White House unveils plan to eliminate threat of fentanyl laced with xylazine
Bags of heroin, some laced with fentanyl, are displayed before a press conference at the office of the New York Attorney General regarding a major drug bust, Sept. 23, 2016. Drew Angerer | Getty Images The Biden administration unveiled a plan Tuesday to eliminate the growing threat of fentanyl laced with xylazine, an illegal street […]
Read More
Novavax stock spikes 20% after company snags $350 million from Canada for unused Covid shots
Nikos Pekiaridis | Nurphoto | Getty Images Stock Chart IconStock chart icon Novavax shares jump on news of a settlement payment from the Canadian government. It’s unclear how many doses of Novavax’s jab – its only commercially available product after 35 years – went unused. Under the amended agreement, Novavax will also provide Canada with […]
Read More
European regulator to evaluation pounds-reduction prescription drugs adhering to stories of suicidal thoughts
Deals of the bodyweight-decline drug Wegovy from the pharmaceutical business Novo Nordisk lie on the income counter in a Danish pharmacy. Stefan Trumpf | Image Alliance | Getty Visuals The European Medicines Agency claimed Monday it would undertake a critique into a quantity of medication applied to handle obesity and diabetic issues immediately after it […]
Read More
Sales of Alzheimer’s drug Leqembi may be slow initially but could pick up in 2024
Jay Reinstein, who suffers from Alzheimer’s, receives an injection so he can have a PET scan at MedStar Georgetown University Hospital in Washington, DC on June 20, 2023. Michael Robinson Chávez | The Washington Post | Getty Images Sales of the Alzheimer’s drug Leqembi may be slow initially due to logistical requirements but could pick […]
Read More
U.S. officials say risk of locally acquired malaria remains low as nationwide cases jump to seven
Barrington Sanders, a Miami-Dade Mosquito Control Inspector, sprays a pesticide to kill adult mosquitos on June 29, 2023 in Miami, Florida. Joe Raedle | Getty Images U.S. public health officials say the risk of locally transmitted malaria in the country remains low as seven new cases in Florida and Texas raise questions. The Florida Department […]
Read More
Japanese pharma Eisai slides 4% even with Fda approval for Alzheimer’s drug
Signage for Eisai Co. at the company’s headquarters in Tokyo, Japan, on Friday, Feb. 3, 2023. Bloomberg | Bloomberg | Getty Visuals Shares of Japanese pharmaceutical huge Eisai sank Friday following the company’s Alzheimer’s drug was formally accredited by U.S. regulators overnight, prompting queries about trader sentiment surrounding the shift. Tokyo-outlined shares of Eisai fell […]
Read More
Moderna strikes deal to develop mRNA drugs in China
Nikos Pekiaridis | Nurphoto | Getty Images Moderna on Wednesday said it struck a deal with Chinese officials to research, develop and manufacture messenger RNA medicines in the country, despite rising tensions between the U.S. and China. The Massachusetts-based biotech company signed a memorandum of understanding and a related land collaboration deal to develop drugs […]
Read More
People should stop taking Ozempic, Wegovy obesity drugs before surgery, doctors group says
In this photo illustration, a box of the diabetes drug Ozempic rests on a pharmacy counter on April 17, 2023 in Los Angeles, California. Mario Tama | Getty Images People on diabetes and weight loss drugs such as Novo Nordisk‘s Ozempic and Wegovy should stop taking them before having elective surgery to reduce the risk […]
Read More
Ex-Pfizer employee charged with illegal trading based on unreleased Covid pill trial data
Federal authorities charged a former Pfizer employee and his close friend Thursday with illegally trading shares based on non-public trial results on the pharmaceutical company’s Covid antiviral pill Paxlovid. The Justice Department and the Securities and Exchange Commission both announced respective insider trading charges against Amit Dagar, a former senior statistical programming lead at Pfizer, […]
Read More